skip to main content

H.Res. 279 (112th): Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

5/25/2011--Introduced. Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.

Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.